CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells

British Journal of Cancer

Volumn 96, Issue 12, 2007, Pages 1839-1848

  Kabingu, E ^a,b   Vaughan, L ^a   Owczarczak, B ^a   Ramsey, K D ^a   Gollnick, S O ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Virion Systems Inc   (United States)

Author keywords

NK cells; PDT; T cells; Tumour immunity

Indexed keywords

PHOTOFRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; HYPOTHESIS; IMMUNE RESPONSE; LOCAL THERAPY; LUNG TUMOR; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN TUMOR; SPLEEN; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; KILLER CELLS, NATURAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 34250376737     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603792     Document Type: Article

References (63)

1. Adam C, King S, Allgeier T, Braumuller H, Luking C, Mysliwietz J, Kriegeskorte A, Busch DH, Rocken M, Mocikat R (2005) DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 106: 338-344
2. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680
3. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC (2002) Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76: 12388-12393
4. Bennett SRM, Carbone FR, Karamalis R, Flavell RZ, Miller JFAP, Heath WR (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-483
5. Blank M, Lavie G, Mandel M, Keisari Y (2001) Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. Oncol Res 12: 409-418
6. Brown SB, Brown EA, Walker I (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5: 497-508
7. Bullock TN, Yagita H (2005) Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. J Immunol 174: 710-717
8. Canti G, De Simone A, Korbelik M (2002) Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 1: 79-80
9. Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6: 535-545
10. Castano AP, Gad R, Zahra T, Hamblin MR (2003) Specific anti-tumor immune response with photodynamic therapy mediated by benzoporphyrin derivative and chlorin(e6). In Proc SPIE Laser-Tissue Interaction XIV Jacques SL, Duncan DD, Kirkpatrick SJ, Kriete A (eds). [4961]: 1-9
11. + T cells: when, where, and how. Annu Rev Immunol 24: 519-540
12. Cecic I, Korbelik M (2002) Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett 183: 43-51
13. Cecic I, Parkins CS, Korbelik M (2001) Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem Photobiol 74: 712-720
14. Cecic I, Stott B, Korbelik M (2006) Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol 6: 1259-1266
15. + T cells. Infect Immunity 73: 4913-4921
16. de Vree WJ, Essers MC, Koster JF, Sluiter W (1997) Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based phtodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res 57: 2555-2558
17. Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7
18. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic Therapy. J Natl Cancer Inst 90: 889-905
19. Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13: 114-119
20. Gollnick SO, Evans SE, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, Henderson BW (2003) Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88: 1772-1779
21. Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW (1997) Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57: 3904-3909
22. Gollnick SO, Owczarczak B, Maier P (2006) Photodynamic therapy and anti-tumor immunity. Lasers Surg Med 38: 509-515
23. Gomer CJ, Ferrairo A, Murphree AL (1987) The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer 56: 27-32
24. Henderson BW, Gollnick SO (2003) Mechanistic principles of photodynamic therapy. In Biomedical Photonics Handbook Vo-Dinh T (ed). pp. 36-1-36-27. Boca Raton, FL: CRC Press
25. Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, Cheney RT, Morgan J (2004) Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res 64: 2120-2126
26. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following Photodynamic Therapy. Cancer Res 45: 572-576
27. Hendrzak-Henion JA, Knisely TL, Cincotta L, Cincotta E, Cincotta AH (1999) Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy. Photochem Photobiol 69: 575-581
28. Janeway CA, Medzhitov R (2002) Innate immune recognition. Ann Rev Immunol 20: 197-216
29. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP (2003) CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856
30. Kaisho T, Akira S (2003) Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 3: 373-385
31. Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3: 83-90
32. Korbelik M, Dougherty GJ (1999) Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 59: 1941-1946
33. Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 65: 1018-1026
34. Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106: 263-266
35. Marzo AL, Vezys V, Klonowski KD, Lee S-J, Muralimohan G, Moore M, Tough DF, Lefrançois L (2004) Fully functional memory CD8 T cells in the absence of CD4 T cells. J Immunol 173: 969-975
36. Matzinger P (1994) Tolerance, danger, and the extended family. Ann Rev Immunol 12: 991-1045
37. Matzinger P (2002) The danger model: a renewed sense of self. Science 296: 301-305
38. low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19: 561-569
39. Momma T, Hamblin MR, Wu HC, Hasan T (1998) Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res 58: 5425-5431
40. Moseley P (2000) Stress proteins and the immune response. Immunopharmacology 48: 299-302
41. Nestle FO, Banchereau J, Hart D (2001) Dendritic cells: On the move from bench to bedside. Nat Med 7: 761-765
42. Nseyo UO, Whalen RK, Duncan MR, Berman B, Lundahl SL (1990) Urinary cytokines following photodynamic therapy for bladder cancer. Urology 36: 167-171
43. Oleinick NL, Evans HH (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150(5 Suppl): S146-S156
44. Pulaski B, Yeh K, Shastri N, Maltby KM, Penney DP, Lord EM, Frelinger JG (1996) Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex re-presentation of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci USA 93: 3669-3674
45. Ribas A, Butterfield LH, Amarnani SN, Dissette VB, Kim D, Meng WS, Miranda GA, Wang HJ, McBride WH, Glaspy JA, Economou JS (2001) CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Cancer Res 61: 8787-8793
46. + T-helper and a T-killer cell. Nature 393: 474-478
47. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (2006) SEER Cancer Statistics Review, 1975-2003. http://seer cancer gov/csr/1975_2003/ National Cancer Institute, Bethesda, MD
48. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950
49. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 345: 258-260
50. Schreiber S, Gross S, Brandis A, Harmelin A, Rosenbach-Belkin V, Scherz A, Salomon Y (2002) Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int J Cancer 99: 279-285
51. Shedlock DJ, Shen H (2003) Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339
52. + T cells derived from in vitro dendritic cell activation. Inter Immunol 18: 887 -895
53. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521
54. Siemann DW, Lord EM, Keng PC, Wheeler KT (1981) Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation. Br J Cancer 44: 100-108
55. Sun JC, Bevan MJ (2003) Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342
56. Sun JC, Williams MA, Bevan MJ (2004) CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5: 927-933
57. Tanaka T, Kitamura F, Nagasaka Y, Kuida K, Suwa H, Miyasaka M (1993) Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 178: 1103-1107
58. van Duijnhoven FH, Aalbers RI, Rovers JP, Terpstra OT, Kuppen PJ (2003) Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem Photobiol 78: 235-240
59. van Mierlo GJ, Boonman ZF, Dumortier HM, den Boer AT, Fransen MF, Nouta J, van d V, Offringa R, Toes RE, Melief CJ (2004) Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication. J Immunol 173: 6753-6759
60. Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z (2004) Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4T cells. J Immunol 173: 4590-4597
61. Yom SS, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM (2003) Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem Photobiol 78: 75-81
62. 6- photodynamic therapy in Buffalo rats. Neoplasma 44: 192 -196
63. Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295-307